206 related articles for article (PubMed ID: 21460252)
1. AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma.
Namiki T; Tanemura A; Valencia JC; Coelho SG; Passeron T; Kawaguchi M; Vieira WD; Ishikawa M; Nishijima W; Izumo T; Kaneko Y; Katayama I; Yamaguchi Y; Yin L; Polley EC; Liu H; Kawakami Y; Eishi Y; Takahashi E; Yokozeki H; Hearing VJ
Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6597-602. PubMed ID: 21460252
[TBL] [Abstract][Full Text] [Related]
2. NUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation.
Namiki T; Yaguchi T; Nakamura K; Valencia JC; Coelho SG; Yin L; Kawaguchi M; Vieira WD; Kaneko Y; Tanemura A; Katayama I; Yokozeki H; Kawakami Y; Hearing VJ
Cancer Res; 2015 Jul; 75(13):2708-15. PubMed ID: 25832654
[TBL] [Abstract][Full Text] [Related]
3. NUAK2: an emerging acral melanoma oncogene.
Namiki T; Coelho SG; Hearing VJ
Oncotarget; 2011 Sep; 2(9):695-704. PubMed ID: 21911917
[TBL] [Abstract][Full Text] [Related]
4. Activated Akt expression is associated with the recurrence of primary melanomas and further refines the prognostic and predictive values for relapse in acral melanomas.
Nojima K; Hayashi M; Tanemura A; Al-Busani H; Saito T; Suzuki T; Ishikawa M; Mori T; Wada S; Yamazaki N; Katayama I; Mori H; Yokozeki H; Okiyama N; Sasaki Y; Namiki T
Pigment Cell Melanoma Res; 2024 Jan; 37(1):36-44. PubMed ID: 37596787
[TBL] [Abstract][Full Text] [Related]
5. Aurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells.
Bonet C; Giuliano S; Ohanna M; Bille K; Allegra M; Lacour JP; Bahadoran P; Rocchi S; Ballotti R; Bertolotto C
J Biol Chem; 2012 Aug; 287(35):29887-98. PubMed ID: 22767597
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor β (TGFβ) induces NUAK kinase expression to fine-tune its signaling output.
Kolliopoulos C; Raja E; Razmara M; Heldin P; Heldin CH; Moustakas A; van der Heide LP
J Biol Chem; 2019 Mar; 294(11):4119-4136. PubMed ID: 30622137
[TBL] [Abstract][Full Text] [Related]
7. miR-143 inhibits oncogenic traits by degrading NUAK2 in glioblastoma.
Fu TG; Wang L; Li W; Li JZ; Li J
Int J Mol Med; 2016 Jun; 37(6):1627-35. PubMed ID: 27081712
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis.
Li J; Cheng Y; Tai D; Martinka M; Welch DR; Li G
Oncogene; 2011 Feb; 30(8):896-906. PubMed ID: 20935672
[TBL] [Abstract][Full Text] [Related]
9. SERINE-910 Phosphorylated Focal Adhesion Kinase Expression Predicts Better Overall and Disease-free Survival in Melanoma.
Najjar S; Homan S; Sheehan C; Carlson JA
Appl Immunohistochem Mol Morphol; 2020 Feb; 28(2):130-138. PubMed ID: 32044881
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of NUAK2: A novel prognostic marker in breast cancer.
Chen B; Wang B; Xu X; Chen X; Yi W; Xu S; Wang J
Histol Histopathol; 2023 Jul; 38(7):811-822. PubMed ID: 36440828
[TBL] [Abstract][Full Text] [Related]
11. Uncoupling protein 2 is upregulated in melanoma cells and contributes to the activation of Akt/mTOR and ERK signaling.
Li J; Jia Y; An L; Niu C; Cong X; Zhao Y
Int J Oncol; 2020 May; 56(5):1252-1261. PubMed ID: 32319575
[TBL] [Abstract][Full Text] [Related]
12. Identification of key candidate genes involved in melanoma metastasis.
Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
[TBL] [Abstract][Full Text] [Related]
13. Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.
Li M; Jin C; Xu M; Zhou L; Li D; Yin Y
Cell Commun Signal; 2017 Dec; 15(1):52. PubMed ID: 29246230
[TBL] [Abstract][Full Text] [Related]
14. Targeted knockdown of polo-like kinase 1 alters metabolic regulation in melanoma.
Gutteridge RE; Singh CK; Ndiaye MA; Ahmad N
Cancer Lett; 2017 May; 394():13-21. PubMed ID: 28235541
[TBL] [Abstract][Full Text] [Related]
15. lncRNA FGD5‑AS1 promotes breast cancer progression by regulating the hsa‑miR‑195‑5p/NUAK2 axis.
Fang K; Xu ZJ; Jiang SX; Tang DS; Yan CS; Deng YY; Zhao FY
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880593
[TBL] [Abstract][Full Text] [Related]
16.
Li P; He J; Yang Z; Ge S; Zhang H; Zhong Q; Fan X
Autophagy; 2020 Jul; 16(7):1186-1199. PubMed ID: 31462126
[TBL] [Abstract][Full Text] [Related]
17. Association between phosphorylated AMP-activated protein kinase and MAPK3/1 expression and prognosis for patients with gastric cancer.
Kim JG; Lee SJ; Chae YS; Kang BW; Lee YJ; Oh SY; Kim MC; Kim KH; Kim SJ
Oncology; 2013; 85(2):78-85. PubMed ID: 23860205
[TBL] [Abstract][Full Text] [Related]
18. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
19. 14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence.
Schultz J; Ibrahim SM; Vera J; Kunz M
Mol Cancer; 2009 Jul; 8():53. PubMed ID: 19642975
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of thrombospondin 2 inhibits metastasis through modulation of PI3K signaling pathway in uveal melanoma cell line M23.
Liu QH; Ma LS
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6230-6238. PubMed ID: 30338785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
